Using GM-CSF/IL-4 bone marrow-derived DCs (BMDCs) for vaccination in combination with pomalidomide and PD-L1 blockade, a significant tumor growth inhibition within a multiple myeloma mouse model could be achieved (113). This evidence concerns the gene CD274 and plasma cell myeloma.